 |
 |

Why Is HIV Rarely Transmitted by Oral Secretions?
Saliva Can Disrupt Orally Shed, Infected Leukocytes
Samuel Baron, MD;
Joyce Poast, BS;
Miles W. Cloyd, PhD
Arch Intern Med. 1999;159:303-310.
Background Oral transmission of human immunodeficiency virus (HIV) by the millions of HIV-infected individuals is a rare event, even when infected blood and exudate is present. Saliva of viremic individuals usually contains only noninfectious components of HIV indicating virus breakdown.
Objective To determine whether unknown HIV inhibitory mechanisms may explain the almost complete absence of infectious HIV in the saliva.
Methods Since most of the infectious HIV that is shed mucosally by asymptomatic individuals is found in, produced by, and transmitted by infected mononuclear leukocytes, we determined whether saliva, which is hypotonic, may disrupt these infected cells, thereby preventing virus multiplication and cell-to-cell transmission of HIV. Specifically, we measured (1) whether mononuclear leukocytes were lysed by saliva and (2) whether the lysis by saliva inhibits the multiplication of HIV and other viruses in infected leukocytes and other cells.
Results Saliva rapidly disrupted 90% or more of blood mononuclear leukocytes and other cultured cells. Concomitantly, there was a 10,000-fold or higher inhibition of the multiplication of HIV and surrogate viruses. Further experiments indicated that the cell disruption is due to the hypotonicity of saliva.
Conclusions Hypotonic disruption may be a major mechanism by which saliva kills infected mononuclear leukocytes and prevents their attachment to mucosal epithelial cells and production of infectious HIV, thereby preventing transmission. Implications for the known oral HIV transmission by milk and seminal fluid, as well as potential oral transmission to contacts and health care workers, are considered. This effective salivary defense may be applicable medically to interdict vaginal, rectal, and oral transmission of HIV by infected cells in seminal fluid or milk by the use of anticellular substances.
From the Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Distribution of Tight Junction Proteins in Adult Human Salivary Glands
Maria et al.
J. Histochem. Cytochem. 2008;56:1093-1098.
ABSTRACT
| FULL TEXT
Oral Mucosal Immunity and HIV/SIV Infection
Lu and Jacobson
JDR 2007;86:216-226.
ABSTRACT
| FULL TEXT
Comparison of Human Immunodeficiency Virus Type 1-Specific Inhibitory Activities in Saliva and Other Human Mucosal Fluids
Kazmi et al.
CVI 2006;13:1111-1118.
ABSTRACT
| FULL TEXT
Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Binding Domain of Porphyromonas gingivalis Gingipain.
Xie et al.
Antimicrob. Agents Chemother. 2006;50:3070-3074.
ABSTRACT
| FULL TEXT
Role of Human {beta}-defensins in HIV Infection
Weinberg et al.
ADR 2006;19:42-48.
ABSTRACT
| FULL TEXT
Oral Mucosal Expression of HIV-1 Receptors, Co-receptors, and {alpha}-defensins: Tableau of Resistance or Susceptibility to HIV Infection?
Cutler and Jotwani
ADR 2006;19:49-51.
ABSTRACT
| FULL TEXT
(C3) The Oral Epithelial Cell and First Encounters with HIV-1
Herzberg et al.
ADR 2006;19:158-166.
ABSTRACT
| FULL TEXT
Alternative Modified Infant-Feeding Practices to Prevent Postnatal Transmission of Human Immunodeficiency Virus Type 1 Through Breast Milk: Past, Present, and Future
Hartmann et al.
J Hum Lact 2006;22:75-88.
ABSTRACT
Oral Transmission of HIV, a Rarity: Emerging Hypotheses
Baron
JDR 2001;80:1602-1604.
|